Cargando…
The Synaptic Vesicle Protein 2A Interacts With Key Pathogenic Factors in Alzheimer’s Disease: Implications for Treatment
Alzheimer’s disease (AD), a serious neurodegenerative disease, is pathologically characterized by synaptic loss and dysfunction. Synaptic vesicle protein 2A (SV2A) is an indispensable vesicular protein specifically expressed in synapses and can be used as a biomarker for synaptic density. We found t...
Autores principales: | Kong, Yanyan, Huang, Lin, Li, Weihao, Liu, Xuanting, Zhou, Yinping, Liu, Cuiping, Zhang, Shibo, Xie, Fang, Zhang, Zhengwei, Jiang, Donglang, Zhou, Weiyan, Ni, Ruiqing, Zhang, Chencheng, Sun, Bomin, Wang, Jiao, Guan, Yihui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282058/ https://www.ncbi.nlm.nih.gov/pubmed/34277597 http://dx.doi.org/10.3389/fcell.2021.609908 |
Ejemplares similares
-
Positron Emission Computed Tomography Imaging of Synaptic Vesicle Glycoprotein 2A in Alzheimer’s Disease
por: Kong, Yanyan, et al.
Publicado: (2021) -
Progress of RAGE Molecular Imaging in Alzheimer’s Disease
por: Kong, Yanyan, et al.
Publicado: (2020) -
Pathological Mechanisms Linking Diabetes Mellitus and Alzheimer’s Disease: the Receptor for Advanced Glycation End Products (RAGE)
por: Kong, Yanyan, et al.
Publicado: (2020) -
PET Imaging of Neutrophils Infiltration in Alzheimer's Disease Transgenic Mice
por: Kong, Yanyan, et al.
Publicado: (2020) -
Elucidating the Relationship Between Diabetes Mellitus and Parkinson’s Disease Using (18)F-FP-(+)-DTBZ, a Positron-Emission Tomography Probe for Vesicular Monoamine Transporter 2
por: Kong, Yanyan, et al.
Publicado: (2020)